RAKS PHARMA PVT LTD

Overview

RAKS PHARMA PVT LTD is an active pharmaceutical ingredient (API) supplier with 77 active FDA Type II Drug Master Files, covering ABIRATERONE ACETATE USP; APREMILAST; ATAZANAVIR SULFATE; ATORVASTATIN CALCIUM STABILIZED; AZATHIOPRINE USP; AZATHIOPRINE USP (CODE AZ).

API / Drug Master Files

RAKS PHARMA PVT LTD holds 77 active (77 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PROPRANOLOL HYDROCHLORIDE USPActive2025-08-22
• PRIMIDONE USPActive2024-12-30
• SELENIOUS ACID USPActive2023-10-10
• COLESTIPOL HYDROCHLORIDE USPActive2023-02-24
• AZATHIOPRINE USP (CODE AZ)Active2022-06-30
• CALCIUM GLUCONATE MONOHYDRATE USPActive2022-04-12
• PROCHLORPERAZINE MALEATE USPActive2021-08-27
• DIBASIC POTASSIUM PHOSPHATE USPActive2021-08-26
• MONOBASIC POTASSIUM PHOSPHATE USP-NFActive2021-08-26
• CHLORDIAZEPOXIDE HYDROCHLORIDE USPActive2020-09-28
• CLIDINIUM BROMIDE USPActive2020-09-24
• DOXEPIN HYDROCHLORIDE USPActive2020-08-08
• METYROSINE USPActive2019-06-13
• PROCHLORPERAZINE EDISYLATE USPActive2019-03-28
• BREXPIPRAZOLEActive2018-12-26

Showing 15 of 77 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to RAKS PHARMA PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.